Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frequent Low-Dose Erythropoietin in CKD
NCT03277183Phase 4Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2017
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of erythropoietin in anemia of chronic kidney disease (CKD-A), sponsored by VA Office of Research & Development. Started Nov 2017; status: terminated.
02
Drugs
erythropoietin
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03277183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03277183.